Table 2. Predictive factors and cutoff values for nonresponsiveness to medium-dose IVIG.
Factor | Odds ratio (95% CI) | P value |
---|---|---|
Illness days* | ||
≤5 vs. >6 | 5.47 (1.55-19.24) | 0.008 |
Percentage of neutrophils (%) | ||
≥65 vs. <65 | 0.87 (0.22-3.42) | 0.842 |
C-reactive protein (mg/L) | ||
≥100 vs. <100 | 0.54 (0.16-1.84) | 0.331 |
Aspartate aminotransferase (IU/L) | ||
≥100 vs. <100 | 0.26 (0.04-1.43) | 0.124 |
Alanine aminotransferase (IU/L) | ||
≥200 vs. <200 | 0.88 (0.16-4.85) | 0.887 |
Sodium (mmol/L) | ||
≤136 vs. >136 | 3.63 (1.15-11.41) | 0.027 |
CI, confidence interval; IVIG, intravenous immunoglobulin.
*Illness days: illness days as of initial IVIG administration